Mingsheng Chen

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Squamous Cell Carcinoma

Dendritic Cells

Chronic Lymphocytic Leukemia

Top Venues

International journal of molecular sciences

ACS applied bio materials

This page only lists publications with an associated author ORCID identifier.

Publications

Xudong Xie, Li Li, Shuai Tao, Mingsheng Chen, Ling Fei, Qunling Yang, Chenlu Huang, Liang Chen
Proto-Oncogene FAM50A Can Regulate the Immune Microenvironment and Development of Hepatocellular Carcinoma In Vitro and In Vivo. International journal of molecular sciences 24 (4) (2023)
Xudong Xie, Li Li, Shuai Tao, Mingsheng Chen, Ling Fei, Qunling Yang, Chenlu Huang, Liang Chen
Proto-Oncogene FAM50A Can Regulate the Immune Microenvironment and Development of Hepatocellular Carcinoma In Vitro and In Vivo. International journal of molecular sciences 24 (4) (2023)
Xudong Xie, Li Li, Shuai Tao, Mingsheng Chen, Ling Fei, Qunling Yang, Chenlu Huang, Liang Chen
Proto-Oncogene FAM50A Can Regulate the Immune Microenvironment and Development of Hepatocellular Carcinoma In Vitro and In Vivo. International journal of molecular sciences 24 (4) (2023)
Xudong Xie, Li Li, Shuai Tao, Mingsheng Chen, Ling Fei, Qunling Yang, Chenlu Huang, Liang Chen
Proto-Oncogene FAM50A Can Regulate the Immune Microenvironment and Development of Hepatocellular Carcinoma In Vitro and In Vivo. International journal of molecular sciences 24 (4) (2023)
Xudong Xie, Li Li, Shuai Tao, Mingsheng Chen, Ling Fei, Qunling Yang, Chenlu Huang, Liang Chen
Proto-Oncogene FAM50A Can Regulate the Immune Microenvironment and Development of Hepatocellular Carcinoma In Vitro and In Vivo. International journal of molecular sciences 24 (4) (2023)
Mingsheng Chen, Hao Wang, Hongying Guo, Ying Zhang, Liang Chen
Systematic Investigation of Biocompatible Cationic Polymeric Nucleic Acid Carriers for Immunotherapy of Hepatocellular Carcinoma. Cancers 14 (1) (2021)
Mingsheng Chen, Songhe Zhang, Zhenli He
Controlled Block Polypeptide Composed of d-Type Amino Acids: A Therapeutics Delivery Platform to Inhibit Biofilm Formation of Drug-Resistant Bacteria. ACS applied bio materials 3 (9) (2020)